Biomimetic Upconversion Nanoplatform Synergizes Photodynamic Therapy and Enhanced Radiotherapy against Tumor Metastasis.
Dandan ZhouYun GaoZhe YangNing WangJianxian GeXiaoyi CaoDandan KouYuan GuCang LiMohammad Javad AfshariRuru ZhangCan ChenLing WenShuwang WuJianfeng ZengMingyuan GaoPublished in: ACS applied materials & interfaces (2023)
The easy recurrence and high metastasis of fatal tumors require the development of a combination therapy, which is able to overcome the drawbacks of monomodal strategies such as surgery, photodynamic therapy (PDT), and radiotherapy (RT). Taking the complementary advantages of PDT and RT, we present herein the integration of lanthanide-doped upconversion nanoparticles (UCNPs) with chlorin e6 (Ce6)-imbedded RBC membrane vesicles as a near-infrared-induced PDT agent for achieving synchronous depth PDT and RT with reduced radiation exposure. In such a nanoagent, gadolinium-doped UCNPs with strong X-ray attenuation ability act not only as a light transductor to activate the loaded photosensitizer Ce6 to allow PDT but also as a radiosensitizer to enhance RT. PDT with enhanced low-dose RT can achieve synergistic inhibition of tumor growth by producing reactive oxygen species to destroy local tumor cells and inducing strong T-cell-dependent immunogenic cell death to arrest systemic cancer metastasis. This combination of PDT and RT might be a potential appealing strategy for tumor eradication.
Keyphrases
- photodynamic therapy
- fluorescence imaging
- combination therapy
- cell death
- low dose
- early stage
- reactive oxygen species
- quantum dots
- drug delivery
- minimally invasive
- magnetic resonance imaging
- energy transfer
- high dose
- metal organic framework
- radiation induced
- optical coherence tomography
- computed tomography
- highly efficient
- locally advanced
- helicobacter pylori infection
- coronary artery bypass
- drug induced
- coronary artery disease
- acute coronary syndrome
- free survival
- tissue engineering
- diabetic rats
- rectal cancer